K. de Wit
0000-0001-8472-8549
Amsterdam UMC location AMC
10 papers found
Refreshing results…
Decompensation as initial presentation in patients with liver cirrhosis is associated with an increased risk of future decompensation and mortality
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis.
The use of Rifaximin in Patients with Cirrhosis
The use of Rifaximin in Patients with Cirrhosis.
Doppler follow-up after TIPS placement is not routinely indicated. A 16-years single centre experience.
Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial)
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial
Variable efficacy of TIPSS in the management of ectopic variceal bleeding: a multicentre retrospective study
[A day in the life of a medical resident on the ward].
Prevalence, distribution and risk of sessile serrated adenomas/polyps at a center with a high adenoma detection rate and experienced pathologists
Missing publications? Search for publications with a matching author name.